Early experience with the implementation of the WHO shorter MDR-TB treatment regimen in Singapore

Conclusions: Use of the shorter MDR-TB regimen was constrained by patient eligibility. Poor tolerability and drug adverse effects were universal in our patients.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: She, H. W., Wang, Y. T., Gan, S. H., Chua, A. P. G., Chee, C. B. E. Tags: Tuberculosis Source Type: research